Inventaire - dine venner og fællesskaber er dit bedste bibliotek

Fevipiprant, an oral prostaglandin DP2 receptor (CRTh2) antagonist, in allergic asthma uncontrolled on low-dose inhaled corticosteroids

forfatter

Björn Holzhauer

udgivet i: European Respiratory Journal. Supplement

dato for udgivelse: 2017-08-24

main subject: Allergisk astma

Cites articles 16

Date

Titel

Forfattere

2016-06-21

The oral CRTh2 antagonist QAW039 (fevipiprant): A phase II study in uncontrolled allergic asthma

Todor Popov
2016-05-25

Model selection versus model averaging in dose finding studies

Kirsten Schorning, Frank Bretz
2016-08-05

Fevipiprant, a prostaglandin D2 receptor 2 antagonist, in patients with persistent eosinophilic asthma: a single-centre, randomised, double-blind, parallel-group, placebo-controlled trial

Rachid Berair, Björn Holzhauer, Ian D. Pavord, Andrew Wardlaw, Salman H Siddiqui, Chris Brightling, Amisha Singapuri, Michelle Bourne, Vijay Mistry, Ruth Hartley, Sherif Gonem, Adel H Mansur
2015-04-08

Efficacy of BI 671800, an oral CRTH2 antagonist, in poorly controlled asthma as sole controller and in the presence of inhaled corticosteroid treatment.

Ian P. Hall
2014-06-12

Asthma control and management in 8,000 European patients: the REcognise Asthma and LInk to Symptoms and Experience (REALISE) survey

David Price
2013-12-09

Efficacy of the oral chemoattractant receptor homologous molecule on TH2 cells antagonist BI 671800 in patients with seasonal allergic rhinitis

Jens M. Hohlfeld, Philipp Badorrek
2013-12-03

Model-based dose finding under model uncertainty using general parametric models

Ekkehard Glimm, Frank Bretz
2012-01-01

Consensus document on the diagnosis of severe uncontrolled asthma
2009-02-01

Acute exacerbations of asthma: epidemiology, biology and the exacerbation-prone phenotype
2009-02-01

Efficacy of add-on montelukast in patients with non-controlled asthma: a Belgian open-label study
2008-01-01

The socio-economic burden of asthma is substantial in Europe

Angelo Corsico, Alessandro Marcon, Bénédicte Leynaert
2005-09-01

Combining multiple comparisons and modeling techniques in dose-response studies
2004-07-15

Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study

William W Busse, Jean Bousquet
2004-02-01

Relationship between quality of life and clinical status in asthma: a factor analysis

Paul M O'Byrne
2003-10-01

Montelukast and fluticasone compared with salmeterol and fluticasone in protecting against asthma exacerbation in adults: one year, double blind, randomised, comparative trial

Hans Bisgaard, Stephen Holgate, Leif Bjermer, Tari Haahtela, Jean Bousquet, Leonardo M. Fabbri
1999-12

Montelukast added to inhaled beclomethasone in treatment of asthma. Montelukast/Beclomethasone Additivity Group

Artikel - wd:Q41357528

Welcome to Inventaire

dit venne- og fællesskabs bibliotek

vil du vide mere